Similar live GeM bids
HomeGeM BidsMedical EquipmentGEM/2026/B/7700585
Medical EquipmentGoodsDefenceNew Supply

Procurement of various pharmaceutical tablets including Torsemide, Venlafaxine, Vildagliptin, and Zolpidem for the Indian Army

Indian Army invited bids on GeM for "Procurement of various pharmaceutical tablets including Torsemide, Venlafaxine, Vildagliptin, and Zolpidem for the Indian Army" — a Medical Equipment new supply procurement. Bids close on 03 Jul 2026, 20:30. Quantity 224500. Bid number GEM/2026/B/7700585.
Ministry of Defence » Department of Military Affairs » Indian Army · Bid GEM/2026/B/7700585
Est. value
Not disclosed
Bid closes
03 Jul 2026
15 days left
Quantity
224500
Status
Live

Bid document

Bid details are referenced from GeM (bidplus.gem.gov.in). Live bidding and authoritative documents remain on the official portal.

Complete bid details

Buyer & organisation
Ministry / StateMinistry of Defence
DepartmentDepartment of Military Affairs
OrganisationIndian Army
SectorDefence
Buyer typeCentral
Item & category
ItemTORSEMIDE 10 MG TAB,VENLAFAXINE 75 MG TAB,VILDAGLIPTIN 50 MG TAB,ZOLPIDEM 10 MG TAB
CategoryMedical Equipment
Sub-categoryPharmaceuticals
TypeGoods
ProcurementNew Supply
Quantity224500
Reverse AuctionNo
Make-in-India pref.No
BiddingTwo-packet
Financials & eligibility
Estimated valueNot disclosed
Value tierNot disclosed
EMD requiredNo
ePBG requiredNo
Experience req.3 yrs
MSE-friendlyYes
Startup-friendlyNo
New-seller-friendlyYes
Installation req.No
Inspection req.No
CertificationsNone specified
Delivery
Delivery statesDelhi
ScopeSingle-state

Frequently asked questions

What is this GeM bid for?
Indian Army floated this GeM bid for "Procurement of various pharmaceutical tablets including Torsemide, Venlafaxine, Vildagliptin, and Zolpidem for the Indian Army" under Medical Equipment, procured as new supply.
What is the estimated value?
The value tier was not disclosed for this bid.
When does this bid close?
Bids close on 03 Jul 2026, 20:30.
Is it MSE / startup friendly?
MSE-friendly: Yes; Startup-friendly: No; New-seller-friendly: Yes.